GEA Niro’s Pharma Test Station has extended its range of services within
spray drying to include contract manufacturing at its extensive cGMP
facilities. The service gives pharma companies the option to scale down or
postpone investment into the technology itself and source the service on a
needs basis.
Previously the offer of contract manufacturing was
designed to enable pharmaceutical companies contemplating the purchase of GEA
Niro spray-drying technology to reduce time-to-market. While this is still the
case, the service is no longer limited to companies with such investment plans,
but is extended to all companies within the pharmaceutical business.
GEA Niro’s Pharma Test Station is available for developing
spray-drying processes for pharmaceuticals and pharmaceutical-grade products.
With contract manufacturing it is now possible for companies to order the
production of samples for safety, stability and toxicology studies and of
clinical trials materials. The new service also includes the production of
material for commercial use. Production is run in line with cGMP standards.
“We feel confident that we add considerable value to the businesses of
producers in the pharmaceutical field by extending this service and adding
flexibility to their production set-up,” says Michael Wahlberg, head of the
Test & Development Center at GEA Niro. Michael Wahlberg can be contacted
for further information on
michael.wahlberg@geagroup.com
In 2010 GEA Niro will be attending trade fairs such as CPhI in Paris in
October.
About
The GEA Niro Pharma Test Station is
a fully equipped cGMP spray-drying facility. It includes two GEA Niro
PHARMASDTM spray dryers; a PSD-1 small-scale unit suitable for initial tests
and production of small quantities; and a PSD-4 spray dryer for full-scale
productions. The Pharma Test Station is part of GEA Niro’s Test Center, where
spray-drying process development and initial tests can be performed under
flexible and cost-efficient conditions, avoiding the burden of cGMP
requirements.